AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
24min chapter
Episode 51. Venetoclax in AML with Dr. Andrew Wei
Blood Cancer Talks
Advancements in AML Treatment: Venetoclax and Azacitidine
This chapter explores the impactful VLA study that led to the FDA approval of a combination treatment of azacitidine and venetoclax for older AML patients. It highlights the improved survival rates and the complexities of integrating this new therapy into clinical practice, including the management of risks and variations in physician approaches. Additionally, it discusses the significance of genetic mutations in treatment responses, emphasizing personalized management strategies for better patient outcomes.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode